Product logins

Find logins to all Clarivate products below.


Consumer Digital Marketing in the United States: The Digital Health Journey and Opportunities for Pharma Marketers

The emergence of digital resources in the healthcare system has changed the healthcare experience for U.S. consumers. Online health, consumers’ use of digital resources for health research and care management, is evolving from an info-seeking resource to interactive services and tools that facilitate patient decision making and care management. With pervasive connectivity and the growing market around the seamless transmission of health data among patients, providers, payers, and health systems, consumers have access to digital health resources on multiple screens, in many locations, for an array of health scenarios.

As digital marketers look to execute a more sophisticated patient engagement strategy, they should focus on continuously demonstrating value to the patient. Many marketers must quit solely fighting for broadcast space to promote products, as this is just one tactic, and also begin to leverage the appropriate digital channels that patients access across their health journey to reach patients in their moment of need.

Related Market Assessment Reports

Report
Obesity | Pharmacor | G7 | 2014
Last Updated 29 December 2014 In the simplest of terms, obesity is the result of an imbalance in energy intake versus expenditure, leading to excess energy stores in the form of body fat (adipose…
Report
Hepatitis C Virus | Pharmacor | G7 | 2014
Last Updated 29 December 2014 Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinoma. Treatment of it represents a large untapped market owing to…
Report
Impact of Improving Cancer Survival on Drug-Treatment Opportunities: The Case of CML and Prostate Cancer
Earlier diagnosis and advances in treatment have reduced cancer patients’ mortality over the past decade in the mature markets. Developing markets will continue to see benefits in cancer survival…
Report
Epilepsy | Pharmacor | G7 | 2014
With approximately 5 million patients diagnosed in the seven major pharmaceutical markets, epilepsy is a common, debilitating collection of seizure disorders that affect patients’ quality of life…
Report
Acute Coronary Syndrome | Pharmacor | G7 | 2014
Last Updated 23 December 2014 Acute coronary syndrome (ACS)—an umbrella term that encompasses acute ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI),…